Meanwhile, ALOX5 may be a valuable therapeutic target and prognostic biomarker for bladder cancer, in which the deficiency of ALOX5 might contribute to BCa progression by mediating ferroptosis escape (42). The gene discussed is ALOX5; the disease is urinary bladder cancer.